Reluctant to move after Meloxicam (Metacam) in dogs
The FDA has received 118 reports of reluctant to move in dogs after Meloxicam. That is 1.5% of all reports for this medicine, compared with 0.5% across reports for all dog medicines, so it is reported unusually often with this medicine.
118Reports
34%Marked serious
12%Recovered
20%Died or euthanised
3 daysTypical onset
Sponsored
How soon it started
How the animals did
Problems reported at the same time
Age of the animals
About this medicine
Meloxicam relieves pain and inflammation.
Products with this ingredient include Metacam. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.
NSAIDs can affect the stomach, liver and kidneys. Vets usually recommend blood tests before and during long-term use.
Questions owners ask
- Can Meloxicam cause reluctant to move in dogs?
- 118 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
- How soon after a dose was it reported?
- In half of the reports with dates, it started within 3 days of the first dose.
- What should I do?
- Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).
Reluctant to move with similar medicines
- Reluctant to move after Carprofen (Rimadyl) 580 reports · 1.2% of its reports
- Reluctant to move after Deracoxib (Deramaxx) 140 reports · 1.3% of its reports
- Reluctant to move after Grapiprant (Galliprant) 96 reports · 1.1% of its reports
- Reluctant to move after Firocoxib (Previcox) 111 reports · 1.4% of its reports
All reported side effects of Meloxicam in dogs · Medicines most reported with reluctant to move